Assessment of psychotropic and psychoactive drug loads and falls in nursing facility residents

Consultant Pharmacist

Volumn 22, Issue 6, 2007, Pages 483-489

  Cooper, James W ^a   Freeman, Megan H ^b   Cook, Christopher L ^a   Burfield, Allison H ^c  

^a UNIVERSITY OF GEORGIA   (United States)

^b NORTHSIDE HOSPITAL   (United States)

^c UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

Falls; Psychoactive drugs; Psychotropic drugs; Skilled nursing facility

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; CARBAMAZEPINE; CHLORPHENIRAMINE; DEXTROPROPOXYPHENE; DIAZEPAM; DOXEPIN; FLUOXETINE; FLURAZEPAM; HALOPERIDOL; HYDROCODONE; LORAZEPAM; METOCLOPRAMIDE; MUSCLE RELAXANT AGENT; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; NORTRIPTYLINE; ORPHENADRINE; PHENOBARBITAL; PHENOTHIAZINE DERIVATIVE; PHENYTOIN; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TEMAZEPAM; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

AGED; ARTICLE; DRUG USE; FALL RISK ASSESSMENT; FALLING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING HOME; OBSERVATIONAL STUDY; PRESCRIPTION; SIDE EFFECT;

EID: 34250786692     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2007.483     Document Type: Article

References (30)

1. Kiel DP, O'Sullivan P, Teno JM et al. Health care utilization and functional status in the aged following a fall. Med Care 1991;29: 2218.
2. Tinetti ME, Williams TF, Mayewski R. Fall risk index for elderly based on the number of chronic disabilities. Am J Med 1986;80:429-34.
3. Prudham D, Evans G. Factors associated with falls in the elderly: a community study. Age Ageing 1981;10:14-16.
4. Gryfe CL, Amies A, Ashley MJ. A longitudinal study of falls in an elderly population. I: incidence and morbidity. Age Ageing 1977;6: 201-10.
5. Wild D, Nayak USL, Isaacs B. Characteristics of old people who fell at home. J Clin Exp Geront 1980;2:2717.
6. Cooper JW. Preventing falls and fractures in nursing facility patients. Nurs Home Pract 1994;2:28-30.
7. Cooper JW. Drugs that cause falls in the nursing home. Nurs Homes 1993;42:45-7.
8. Tinetti M, Baker DI, McAvay G et al. A multifactorial intervention to reduce the risk of falling among elderly living in the community. N Engl J Med 1994;331:821-7.
9. Sloane PD, Mathew LJ, Scarborough M et al. Physical and pharmacologic restraints of nursing home patients with dementia. JAMA 1991;265:1278-82.
10. Buck JA. Psychotropic drug practice in nursing homes. J Am Geriatr Soc 1988;36:409-18.
11. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination halflife and the risk of hip fracture. JAMA 1989;62:330-7.
12. Jansen EC, Wachowiak-Anderson G, Munster-Swendsen J et al. Postural stability after oral premedication with diazepam. Anesthesiol 1985;65:55-79.
13. Cooper JW. Falls and fractures in nursing home patients receiving psychotropic drugs. Int J Geriatr Psych 1994;9:975-80.
14. Greenblatt DJ, Harmatz JS, Shapiro L et al. Sensitivity to triazolam in the elderly. N Engl J Med 1991;324:1691-8.
15. Cooper JW Falls in nursing home patients receiving classical antihistamines while stabilized on psychoactive medications. J Pharmacocpid 1996;5:45-51.
16. Ray WR, Griffin MR, Schaffner et al. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987;316:363-9.
17. Cooper JW, Cobb HH, Burfield AH. Buspirone conversion effect on falls, injuries, behavior and costs in a rural geriatric nursing home population. Consult Pharm 2001;16:358-63.
18. Cooper JW. Consultant pharmacist assessment and reduction of fall risk in nursing facilities. Consult Pharm 1997;12:1294-304.
19. Cooper JW. Consultant pharmacist assessment of fall injury incidence and costs within a nursing facility. Consult Pharm 1997;12:1305-9.
20. Cooper JW. Reducing falls among patients in nursing homes. JAMA 1997;278:1742.
21. Leipzig RM, Cumming RG, Tinetti ME et al. Drugs and falls in older people: a systematic review and meta-analysis. I: psychotropic drugs. J Am Geriatr Soc 1999;47:30-9.
22. Cooper JW. Adverse drug reaction-related hospitalizations of nursing facility patients: a 4-year study. South Med J 1999;92:485-90.
23. Sleeper R, Bond CA, Rojas-Fernandez C. Psychotropic drugs and falls: new evidence pertaining to serotonin reuptake inhibitors. Pharmacother 2000;20:308-17.
24. Weiner DK, Hanlon JT, Studenski SA. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontol 1998;44:217-21.
25. Cooper JW. Drugs may have reduced effect of falls intervention. BMJ 2001;322:675.
26. Cooper JW. Reducing psychotropic drugs reduces falls in elderly people. BMJ 2001;323:402.
27. Reisberg B, Ferris SH, deLeon MJ et al. A global deterioration scale for assessing dementia. Am J Psych 1982;139:1136-9.
28. Nurmi-Luthje I, Kaukonen JP, Luthje P et al. Use of benzodiazepines and benzodiazepine-related drugs among 223 patients with an acute hip fracture in Finland: comparison of benzodiazepine findings in medical records and laboratory assays. Drugs Aging 2006;23:27-37.
29. Landi F, Onder G, Cesari M et al. Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci 2005;60:622-6.
30. Ray WA, Thapa PB, Gideon P. Benzodiazepines and the risk of falls in nursing home residents. J Am Geriatr Soc 2000;48:682-5.